ASX - By Stock
|
NEU |
Re:
An Up Front...
|
|
Noda
|
21 |
15K |
3 |
08/11/17 |
08/11/17 |
ASX - By Stock
|
21
|
15K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Reverse Rett Syndrome
|
|
Noda
|
49 |
31K |
20 |
03/11/17 |
03/11/17 |
ASX - By Stock
|
49
|
31K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Reverse Rett Syndrome
|
|
Noda
|
49 |
31K |
39 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
49
|
31K
|
39
|
|
ASX - By Stock
|
NEU |
Re:
TBI Breaking News
|
|
Noda
|
6 |
5.1K |
12 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
6
|
5.1K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Deal Pending
|
|
Noda
|
360 |
206K |
38 |
27/10/17 |
27/10/17 |
ASX - By Stock
|
360
|
206K
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Deal Pending
|
|
Noda
|
360 |
206K |
29 |
26/10/17 |
26/10/17 |
ASX - By Stock
|
360
|
206K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Deal Pending
|
|
Noda
|
360 |
206K |
17 |
25/10/17 |
25/10/17 |
ASX - By Stock
|
360
|
206K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Deal Pending
|
|
Noda
|
360 |
206K |
8 |
23/10/17 |
23/10/17 |
ASX - By Stock
|
360
|
206K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Deal Pending
|
|
Noda
|
360 |
206K |
15 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
360
|
206K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
|
|
Noda
|
138 |
66K |
37 |
13/10/17 |
13/10/17 |
ASX - By Stock
|
138
|
66K
|
37
|
|
ASX - By Stock
|
NEU |
Re:
Recent trading .....
|
|
Noda
|
20 |
7.2K |
11 |
13/10/17 |
13/10/17 |
ASX - By Stock
|
20
|
7.2K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
FDA meeting this month.
|
|
Noda
|
128 |
68K |
1 |
10/10/17 |
10/10/17 |
ASX - By Stock
|
128
|
68K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
FDA meeting this month.
|
|
Noda
|
128 |
68K |
1 |
10/10/17 |
10/10/17 |
ASX - By Stock
|
128
|
68K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
FDA meeting this month.
|
|
Noda
|
128 |
68K |
20 |
05/10/17 |
05/10/17 |
ASX - By Stock
|
128
|
68K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
FDA meeting this month.
|
|
Noda
|
128 |
68K |
30 |
03/10/17 |
03/10/17 |
ASX - By Stock
|
128
|
68K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
FDA meeting this month.
|
|
Noda
|
128 |
68K |
11 |
02/10/17 |
02/10/17 |
ASX - By Stock
|
128
|
68K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Is Neuren the cheapest biotech stock in Australia .
|
|
Noda
|
66 |
35K |
8 |
12/09/17 |
12/09/17 |
ASX - By Stock
|
66
|
35K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
BP update
|
|
Noda
|
13 |
12K |
24 |
06/09/17 |
06/09/17 |
ASX - By Stock
|
13
|
12K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
BP update
|
|
Noda
|
13 |
12K |
5 |
31/08/17 |
31/08/17 |
ASX - By Stock
|
13
|
12K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Americans view of "Penny Stocks"
|
|
Noda
|
2 |
1.4K |
8 |
22/08/17 |
22/08/17 |
ASX - By Stock
|
2
|
1.4K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notice of special meeting of shareholders
|
|
Noda
|
36 |
19K |
5 |
18/08/17 |
18/08/17 |
ASX - By Stock
|
36
|
19K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notice of special meeting of shareholders
|
|
Noda
|
36 |
19K |
7 |
18/08/17 |
18/08/17 |
ASX - By Stock
|
36
|
19K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notice of special meeting of shareholders
|
|
Noda
|
36 |
19K |
2 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
36
|
19K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
A comparison orphan drug
|
|
Noda
|
10 |
5.7K |
5 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
10
|
5.7K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Below benchmark for 1st month
|
|
Noda
|
48 |
22K |
11 |
04/08/17 |
04/08/17 |
ASX - By Stock
|
48
|
22K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Below benchmark for 1st month
|
|
Noda
|
48 |
22K |
6 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
48
|
22K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Below benchmark for 1st month
|
|
Noda
|
48 |
22K |
8 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
48
|
22K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Below benchmark for 1st month
|
|
Noda
|
48 |
22K |
5 |
28/07/17 |
28/07/17 |
ASX - By Stock
|
48
|
22K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Becoming a substantial holder
|
|
Noda
|
16 |
9.6K |
19 |
21/07/17 |
21/07/17 |
ASX - By Stock
|
16
|
9.6K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren granted Type B Meeting with FDA for Rett syndrome
|
|
Noda
|
12 |
6.8K |
1 |
21/07/17 |
21/07/17 |
ASX - By Stock
|
12
|
6.8K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
FDA meeting
|
|
Noda
|
20 |
8.6K |
17 |
19/07/17 |
19/07/17 |
ASX - By Stock
|
20
|
8.6K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notice under section 708A(5)(e) of the Corporations Act
|
|
Noda
|
1 |
1.4K |
6 |
14/07/17 |
14/07/17 |
ASX - By Stock
|
1
|
1.4K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
28 |
06/07/17 |
06/07/17 |
ASX - By Stock
|
73
|
39K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
bell potter
|
|
Noda
|
43 |
24K |
17 |
05/07/17 |
05/07/17 |
ASX - By Stock
|
43
|
24K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
8 |
05/07/17 |
05/07/17 |
ASX - By Stock
|
73
|
39K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
5 |
05/07/17 |
05/07/17 |
ASX - By Stock
|
73
|
39K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
11 |
04/07/17 |
04/07/17 |
ASX - By Stock
|
73
|
39K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
bell potter
|
|
Noda
|
43 |
24K |
5 |
03/07/17 |
03/07/17 |
ASX - By Stock
|
43
|
24K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Uncertainty
|
|
Noda
|
6 |
3.0K |
11 |
03/07/17 |
03/07/17 |
ASX - By Stock
|
6
|
3.0K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
AGM
|
|
Noda
|
27 |
14K |
18 |
03/07/17 |
03/07/17 |
ASX - By Stock
|
27
|
14K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
5 |
30/06/17 |
30/06/17 |
ASX - By Stock
|
73
|
39K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
3 |
30/06/17 |
30/06/17 |
ASX - By Stock
|
73
|
39K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2017 AGM Chairman's Address
|
|
Noda
|
14 |
7.4K |
13 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
14
|
7.4K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
3 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
73
|
39K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
5 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
73
|
39K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2017 AGM Chairman's Address
|
|
Noda
|
14 |
7.4K |
13 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
14
|
7.4K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren secures funding for key activities for Rett syndrome
|
|
Noda
|
73 |
39K |
8 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
73
|
39K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
52 |
31K |
19 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
52
|
31K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
52 |
31K |
11 |
28/06/17 |
28/06/17 |
ASX - By Stock
|
52
|
31K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
52 |
31K |
32 |
27/06/17 |
27/06/17 |
ASX - By Stock
|
52
|
31K
|
32
|
|